NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Caribou Biosciences Inc. Common Stock (NASDAQ: CRBU)

 
CRBU Technical Analysis
5
As on 16th May 2025 CRBU STOCK Price closed @ 0.94 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.80 & Strong Sell for SHORT-TERM with Stoploss of 5.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CRBUSTOCK Price

Open 0.83 Change Price %
High 0.94 1 Day 0.10 11.90
Low 0.82 1 Week 0.18 23.68
Close 0.94 1 Month 0.16 20.51
Volume 1189978 1 Year -5.02 -84.23
52 Week High 8.26 | 52 Week Low 0.73
 
NASDAQ USA Most Active Stocks
AFMD 0.28 211.11%
AMRS 0.14 100.00%
HCTI 0.01 -75.00%
BON 0.06 20.00%
PLUG 0.77 10.00%
NVDA 135.40 0.42%
AGMH 0.07 16.67%
GNLN 0.01 0.00%
LCID 2.84 5.58%
LMDX 0.02 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
AFMD 0.28 211.11%
NDRAW 0.03 200.00%
INZY 3.95 178.17%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
BCAC 22.71 125.30%
 
NASDAQ USA Top Losers Stocks
CTHR 0.02 -98.00%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
TBIO 0.01 -83.33%
NBSTU 2.00 -82.44%
ZWZZT 10.00 -75.50%
HCTI 0.01 -75.00%
SRAX 0.10 -73.68%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
 
 
CRBU
Daily Charts
CRBU
Intraday Charts
Whats New @
Bazaartrend
CRBU
Free Analysis
 
CRBU Important Levels Intraday
RESISTANCE1.17
RESISTANCE1.10
RESISTANCE1.05
RESISTANCE1.01
SUPPORT0.87
SUPPORT0.83
SUPPORT0.78
SUPPORT0.71
 
CRBU Forecast May 2025
4th UP Forecast5.03
3rd UP Forecast3.72
2nd UP Forecast2.91
1st UP Forecast2.1
1st DOWN Forecast-0.22
2nd DOWN Forecast-1.03
3rd DOWN Forecast-1.84
4th DOWN Forecast-3.15
 
CRBU Weekly Forecast
4th UP Forecast4.02
3rd UP Forecast3.03
2nd UP Forecast2.42
1st UP Forecast1.81
1st DOWN Forecast0.07
2nd DOWN Forecast-0.54
3rd DOWN Forecast-1.15
4th DOWN Forecast-2.14
 
CRBU Forecast2025
4th UP Forecast15.72
3rd UP Forecast10.98
2nd UP Forecast8.05
1st UP Forecast5.12
1st DOWN Forecast-3.24
2nd DOWN Forecast-6.17
3rd DOWN Forecast-9.1
4th DOWN Forecast-13.84
 
 
CRBU Other Details
Segment EQ
Market Capital 1319657344.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CRBU Address
CRBU
 
CRBU Latest News
 
Your Comments and Response on Caribou Biosciences Inc. Common Stock
 
CRBU Business Profile
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. Caribou Biosciences has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California. Address: 2929 7th Street, Berkeley, CA, United States, 94710
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service